nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—CYP3A4—bone cancer	0.619	1	CbGaD
Silodosin—UGT2B7—Epirubicin—bone cancer	0.249	0.73	CbGbCtD
Silodosin—ABCB1—Cisplatin—bone cancer	0.0339	0.0992	CbGbCtD
Silodosin—ABCB1—Doxorubicin—bone cancer	0.0227	0.0665	CbGbCtD
Silodosin—ABCB1—Methotrexate—bone cancer	0.022	0.0644	CbGbCtD
Silodosin—CYP3A4—Doxorubicin—bone cancer	0.0136	0.0398	CbGbCtD
Silodosin—ABCB4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00413	0.108	CbGpPWpGaD
Silodosin—ABCB4—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.00384	0.101	CbGpPWpGaD
Silodosin—UGT2B7—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00265	0.0696	CbGpPWpGaD
Silodosin—ABCB4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00241	0.0634	CbGpPWpGaD
Silodosin—Tamsulosin—CYP3A4—bone cancer	0.00207	1	CrCbGaD
Silodosin—UGT2B7—Estrogen metabolism—CYP3A4—bone cancer	0.00138	0.0364	CbGpPWpGaD
Silodosin—UGT2B7—Tamoxifen metabolism—CYP3A4—bone cancer	0.00122	0.0322	CbGpPWpGaD
Silodosin—UGT2B7—Metapathway biotransformation—CYP4V2—bone cancer	0.00113	0.0298	CbGpPWpGaD
Silodosin—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000987	0.0259	CbGpPWpGaD
Silodosin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000925	0.0243	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000923	0.0243	CbGpPWpGaD
Silodosin—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000606	0.0159	CbGpPWpGaD
Silodosin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00057	0.015	CbGpPWpGaD
Silodosin—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00054	0.0142	CbGpPWpGaD
Silodosin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000531	0.014	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—GRM1—bone cancer	0.00051	0.0134	CbGpPWpGaD
Silodosin—ADRA1D—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000397	0.0104	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—NDUFA12—bone cancer	0.000395	0.0104	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—GNA11—bone cancer	0.000362	0.0095	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—SMO—bone cancer	0.000359	0.00944	CbGpPWpGaD
Silodosin—UGT2B7—Phase II conjugation—GSTP1—bone cancer	0.000333	0.00874	CbGpPWpGaD
Silodosin—ADRA1B—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000329	0.00865	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—NT5C3A—bone cancer	0.000327	0.0086	CbGpPWpGaD
Silodosin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000327	0.0086	CbGpPWpGaD
Silodosin—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000326	0.00856	CbGpPWpGaD
Silodosin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00031	0.00815	CbGpPWpGaD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.000292	0.00768	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—GRM1—bone cancer	0.000287	0.00753	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000261	0.00685	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000256	0.00674	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—GRM1—bone cancer	0.000238	0.00625	CbGpPWpGaD
Silodosin—UGT2B7—Biological oxidations—CYP3A4—bone cancer	0.000228	0.00598	CbGpPWpGaD
Silodosin—UGT2B7—Metapathway biotransformation—CYP3A4—bone cancer	0.000224	0.0059	CbGpPWpGaD
Silodosin—UGT2B7—NRF2 pathway—TGFBR2—bone cancer	0.000222	0.00583	CbGpPWpGaD
Silodosin—UGT2B7—NRF2 pathway—GSTP1—bone cancer	0.000222	0.00583	CbGpPWpGaD
Silodosin—ADRA1D—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000222	0.00582	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000213	0.00559	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—GRM1—bone cancer	0.000211	0.00555	CbGpPWpGaD
Silodosin—UGT2B7—Biological oxidations—GSTP1—bone cancer	0.000195	0.00511	CbGpPWpGaD
Silodosin—UGT2B7—Metapathway biotransformation—GSTP1—bone cancer	0.000192	0.00504	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000189	0.00497	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—GNA11—bone cancer	0.000185	0.00486	CbGpPWpGaD
Silodosin—ADRA1B—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000184	0.00483	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—MMP2—bone cancer	0.00017	0.00445	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—GRM4—bone cancer	0.000167	0.00438	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000165	0.00434	CbGpPWpGaD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000163	0.00429	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—GNA11—bone cancer	0.000153	0.00403	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—GRM1—bone cancer	0.000145	0.0038	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—ENO2—bone cancer	0.000143	0.00377	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—GRM4—bone cancer	0.000138	0.00364	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000137	0.0036	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—NDUFA12—bone cancer	0.000136	0.00358	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—GNA11—bone cancer	0.000136	0.00358	CbGpPWpGaD
Silodosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000135	0.00355	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—DHFR—bone cancer	0.000133	0.0035	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—JUN—bone cancer	0.000131	0.00344	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—MMP9—bone cancer	0.000127	0.00335	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—GNA11—bone cancer	0.000124	0.00327	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—GRM4—bone cancer	0.000123	0.00323	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000122	0.0032	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—GRM1—bone cancer	0.00012	0.00315	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—NT5C3A—bone cancer	0.000113	0.00297	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CYP3A4—bone cancer	0.000113	0.00296	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000112	0.00295	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000111	0.00291	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—GRM1—bone cancer	0.000107	0.0028	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—EGFR—bone cancer	0.000103	0.00271	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—SMO—bone cancer	0.000102	0.00268	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—GSTP1—bone cancer	9.64e-05	0.00253	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—RGS1—bone cancer	9.42e-05	0.00248	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—GRM4—bone cancer	9.42e-05	0.00248	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	9.41e-05	0.00247	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	8.57e-05	0.00225	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—RGS1—bone cancer	8.56e-05	0.00225	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—GRM4—bone cancer	8.56e-05	0.00225	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—SMO—bone cancer	8.46e-05	0.00222	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—GRM1—bone cancer	8.17e-05	0.00215	CbGpPWpGaD
Silodosin—ADRA1B—AMPK Signaling—TP53—bone cancer	8.14e-05	0.00214	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—RGS1—bone cancer	7.82e-05	0.00206	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—GRM4—bone cancer	7.82e-05	0.00206	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	7.8e-05	0.00205	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	7.69e-05	0.00202	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—SMO—bone cancer	7.51e-05	0.00197	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—GRM1—bone cancer	7.42e-05	0.00195	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	7.29e-05	0.00192	CbGpPWpGaD
Silodosin—ADRA1A—AMPK Signaling—TP53—bone cancer	7.23e-05	0.0019	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—GRM4—bone cancer	7.1e-05	0.00187	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—RGS1—bone cancer	7.1e-05	0.00187	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—RGS1—bone cancer	6.95e-05	0.00183	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—GRM4—bone cancer	6.95e-05	0.00183	CbGpPWpGaD
Silodosin—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.9e-05	0.00181	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—GRM1—bone cancer	6.78e-05	0.00178	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	6.52e-05	0.00171	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.5e-05	0.00171	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—RGS1—bone cancer	6.31e-05	0.00166	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—GRM4—bone cancer	6.31e-05	0.00166	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—GRM1—bone cancer	6.16e-05	0.00162	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—GRM1—bone cancer	6.02e-05	0.00158	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.61e-05	0.00148	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—GRM1—bone cancer	5.47e-05	0.00144	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—GNA11—bone cancer	5.27e-05	0.00138	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—SMO—bone cancer	5.23e-05	0.00137	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NDUFA12—bone cancer	5.08e-05	0.00134	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RGS1—bone cancer	5.06e-05	0.00133	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GRM4—bone cancer	5.06e-05	0.00133	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—PTGS2—bone cancer	5e-05	0.00131	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ENO2—bone cancer	4.95e-05	0.0013	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.84e-05	0.00127	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—GNA11—bone cancer	4.78e-05	0.00126	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—IL3—bone cancer	4.77e-05	0.00125	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	4.71e-05	0.00124	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—DHFR—bone cancer	4.59e-05	0.00121	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.47e-05	0.00117	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.41e-05	0.00116	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GRM1—bone cancer	4.38e-05	0.00115	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—GNA11—bone cancer	4.37e-05	0.00115	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—SMO—bone cancer	4.34e-05	0.00114	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL3—bone cancer	4.34e-05	0.00114	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GNA11—bone cancer	4.29e-05	0.00113	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NT5C3A—bone cancer	4.21e-05	0.00111	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GRM4—bone cancer	4.2e-05	0.0011	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RGS1—bone cancer	4.2e-05	0.0011	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—GNA11—bone cancer	3.97e-05	0.00104	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—IL3—bone cancer	3.96e-05	0.00104	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	3.91e-05	0.00103	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP3A4—bone cancer	3.89e-05	0.00102	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	3.88e-05	0.00102	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—SMO—bone cancer	3.85e-05	0.00101	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GRM4—bone cancer	3.73e-05	0.000979	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RGS1—bone cancer	3.73e-05	0.000979	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GRM1—bone cancer	3.64e-05	0.000956	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL3—bone cancer	3.6e-05	0.000946	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.59e-05	0.000942	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—GNA11—bone cancer	3.53e-05	0.000926	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—IL3—bone cancer	3.52e-05	0.000925	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	3.47e-05	0.000912	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.46e-05	0.000908	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GSTP1—bone cancer	3.33e-05	0.000875	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GRM1—bone cancer	3.23e-05	0.000849	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL3—bone cancer	3.2e-05	0.00084	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NDUFA12—bone cancer	3.13e-05	0.000823	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.12e-05	0.000819	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SMO—bone cancer	3.09e-05	0.000812	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GNA11—bone cancer	2.82e-05	0.000742	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ATF1—bone cancer	2.63e-05	0.00069	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NT5C3A—bone cancer	2.6e-05	0.000682	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SMO—bone cancer	2.56e-05	0.000674	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL3—bone cancer	2.56e-05	0.000673	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.45e-05	0.000644	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GNA11—bone cancer	2.34e-05	0.000616	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SMO—bone cancer	2.28e-05	0.000598	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	2.19e-05	0.000576	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ATF1—bone cancer	2.18e-05	0.000573	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL3—bone cancer	2.13e-05	0.000559	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GNA11—bone cancer	2.08e-05	0.000547	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IGF1R—bone cancer	2.06e-05	0.000542	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.06e-05	0.000541	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ATF1—bone cancer	1.94e-05	0.000509	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL3—bone cancer	1.89e-05	0.000496	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ENO2—bone cancer	1.85e-05	0.000485	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	1.82e-05	0.000478	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTGS2—bone cancer	1.72e-05	0.000453	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—DHFR—bone cancer	1.71e-05	0.00045	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF1R—bone cancer	1.71e-05	0.000449	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	1.61e-05	0.000424	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GNA11—bone cancer	1.6e-05	0.00042	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF1R—bone cancer	1.52e-05	0.000399	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KIT—bone cancer	1.49e-05	0.000393	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP3A4—bone cancer	1.45e-05	0.000381	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—BRAF—bone cancer	1.4e-05	0.000369	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—EGFR—bone cancer	1.36e-05	0.000358	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTP1—bone cancer	1.24e-05	0.000326	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KIT—bone cancer	1.24e-05	0.000326	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.18e-05	0.000309	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.17e-05	0.000306	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ENO2—bone cancer	1.14e-05	0.000299	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.13e-05	0.000297	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KIT—bone cancer	1.1e-05	0.00029	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—DHFR—bone cancer	1.05e-05	0.000277	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.04e-05	0.000272	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—JUN—bone cancer	1.02e-05	0.000269	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1e-05	0.000264	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MMP9—bone cancer	9.95e-06	0.000262	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GNA11—bone cancer	9.86e-06	0.000259	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MDM2—bone cancer	9.77e-06	0.000257	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MDM2—bone cancer	8.68e-06	0.000228	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—JUN—bone cancer	8.49e-06	0.000223	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP9—bone cancer	8.26e-06	0.000217	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EGFR—bone cancer	8.04e-06	0.000211	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTP1—bone cancer	7.64e-06	0.000201	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—JUN—bone cancer	7.54e-06	0.000198	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP9—bone cancer	7.34e-06	0.000193	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TP53—bone cancer	6.75e-06	0.000177	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EGFR—bone cancer	6.68e-06	0.000175	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS2—bone cancer	6.43e-06	0.000169	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EGFR—bone cancer	5.93e-06	0.000156	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TP53—bone cancer	5.61e-06	0.000147	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TP53—bone cancer	4.98e-06	0.000131	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS2—bone cancer	3.96e-06	0.000104	CbGpPWpGaD
